BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Lymphocyte
,
Laryngoscope
,
Clofibrate
,
rs2476601
,
SIRT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
factors, II
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
BMP9 expression in the adult rat brain.
Bone morphogenetic protein-9 downregulates StAR expression by inducing snail expression via SMAD1/5/…
Successful preoperative replacement of prothrombin with prothrombin complex concentrate for Prothrom…
Unique properties of prothrombin in the bullhead shark Heterodontus japonicus: the first report of p…
Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA
Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test
Evaluation of Factors II, VII, IX, X, and Proteins C and S, Following High-dose Vitamin K Supplement…
Effects of Exercise Intervention and Confounding Factors on Type II Diabetic Muscles
MOTHIF II : THERAPEUTIC MANAGEMENT AND USE OF CLOTTING FACTORS IN HEMOPHILIA A & B IN FRANCE II
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ